Bulgaria vs Laos: Cause of death, by non-communicable diseases, ages 60+, male
Bulgaria
76.8%
in 2021
Laos
77.2%
in 2021
Bulgaria rank
62nd
Laos rank
60th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Bulgaria
- Laos
How they compare
Laos currently reports 77.2% against 76.8% in Bulgaria, a difference of 0.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Bulgaria ahead.
Bulgaria ranks 62nd and Laos ranks 60th of 185 countries.
Bulgaria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bulgaria | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.9% | 73.6% | 21.3% | Bulgaria |
| 2010s | 96.3% | 81.4% | 14.8% | Bulgaria |
| 2020s | 82.2% | 81.1% | 1.0% | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Bulgaria or Laos?
- Laos, at 77.2% against 76.8% in Bulgaria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Bulgaria and Laos?
- 0.4%, with Laos ahead.
- How many years of comparable data are there for Bulgaria and Laos?
- 6 years are reported by both, from 2000 to 2021.
- How do Bulgaria and Laos rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Bulgaria ranks 62nd and Laos ranks 60th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.